SCHEMBL5861892

SCHEMBL5861892

Cc1ccc(I)c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912200 0.74
SCHEMBL17238980 0.70
SCHEMBL2303304 0.70
SCHEMBL17207484 0.70
SCHEMBL1738125 0.68 HMBS (0.46)
SCHEMBL65952 0.67
SCHEMBL9972520 0.67
SCHEMBL15269029 0.67 HMBS (0.43)
SCHEMBL14793837 0.67 HMBS (0.43)
SCHEMBL22674257 0.67 HMBS (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106863-A1 LACTAM DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2025-05-22 WO disclosed
US-8975235-B2 Lysophosphatidic acid receptor antagonists INTERMUNE, INC. (US) 2015-03-10 US disclosed
US-7030145-B2 Pyridinyl derivatives for the treatment of depression BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-18 US disclosed
US-20040209917-A1 Pyridinyl derivatives for the treatment of depression HARTZ RICHARD A (US) 2004-10-21 US disclosed